Evasion of regulatory phosphorylation by an alternatively spliced isoform of Musashi2
Related Experiment Video
Updated: Feb 22, 2026

Identification of Alternative Splicing and Polyadenylation in RNA-seq Data
Published on: June 24, 2021
Melanie C MacNicol1,2, Chad E Cragle1, F Kennedy McDaniel1
1University of Arkansas for Medical Sciences, Department of Neurobiology and Developmental Sciences, 4301 W. Markham, Little Rock, 72205, AR, USA.
Abstract:
The Musashi family of RNA binding proteins act to promote stem cell self-renewal and oppose cell differentiation predominantly through translational repression of mRNAs encoding pro-differentiation factors and inhibitors of cell cycle progression. During tissue development and repair however, Musashi repressor function must be dynamically regulated to allow cell cycle exit and differentiation. The mechanism by which Musashi repressor function is attenuated has not been fully established. Our prior work indicated that the Musashi1 isoform undergoes site-specific regulatory phosphorylation. Here, we demonstrate that the canonical Musashi2 isoform is subject to similar regulated site-specific phosphorylation, converting Musashi2 from a repressor to an activator of target mRNA translation. We have also characterized a novel alternatively spliced, truncated isoform of human Musashi2 (variant 2) that lacks the sites of regulatory phosphorylation and fails to promote translation of target mRNAs. Consistent with a role in opposing cell cycle exit and differentiation, upregulation of Musashi2 variant 2 was observed in a number of cancers and overexpression of the Musashi2 variant 2 isoform promoted cell transformation. These findings indicate that alternately spliced isoforms of the Musashi protein family possess distinct functional and regulatory properties and suggest that differential expression of Musashi isoforms may influence cell fate decisions.
Insights
Musashi proteins regulate cell fate. Phosphorylation converts Musashi2 from a repressor to an activator, while a variant 2 isoform promotes cancer by blocking differentiation.
Area of Science:
- Molecular Biology
- Cell Biology
- Developmental Biology
Background:
- Musashi proteins (RNA binding proteins) are crucial for stem cell self-renewal and inhibiting differentiation.
- Their repressor function must be modulated during tissue development and repair.
- Mechanisms for attenuating Musashi repressor activity are not fully understood.
Purpose of the Study:
- To investigate the regulatory phosphorylation of the Musashi2 isoform.
- To characterize a novel alternatively spliced variant of Musashi2.
- To determine the functional and regulatory differences between Musashi isoforms.
Main Methods:
- Site-specific phosphorylation analysis of Musashi2.
- Characterization of a novel truncated human Musashi2 variant (variant 2).
- Assessment of isoform function in target mRNA translation and cell transformation.
Main Results:
- Canonical Musashi2 undergoes regulatory phosphorylation, switching its function from repressor to translational activator.
- A novel, truncated Musashi2 variant 2 lacks phosphorylation sites and fails to activate translation.
- Musashi2 variant 2 is upregulated in cancers and promotes cell transformation.
Conclusions:
- Alternately spliced Musashi isoforms exhibit distinct functional and regulatory properties.
- Differential expression of Musashi isoforms can significantly impact cell fate decisions.
- Musashi2 variant 2 may play a role in cancer development by opposing differentiation.
Related Concept Videos
Phosphorylation
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Nonsense-mediated mRNA Decay
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alternative RNA Splicing
cAMP-dependent Protein Kinase Pathways

